A phase 1 randomized controlled trial has found an Ebola virus disease vaccine was well-tolerated with no safety concerns, and high antibodies were present in participants six months after immunization. User mvea, in the health subreddit, 20 Jun 2017
A phase 1 randomized controlled trial has found an Ebola virus disease vaccine was well-tolerated with no safety concerns, and high antibodies were present in participants six months after immunization. User mvea, in the Future(s) Studies subreddit, 20 Jun 2017